China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year

Aug.22.2025
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (Hong Kong) recorded revenue of HKD 10.32 billion in the first half of 2025, up 18.5% year-on-year, with gross profit down 1.8%. Net profit attributable to shareholders was HKD 706 million, up 9.8% year-on-year. Revenue from the new tobacco export business was HKD 14.6 million, down 66.5% year-on-year.

On the evening of August 22, Beijing time, China Tobacco International (Hong Kong) Company Limited (6055.HK) released its interim results for the period ended June 30, 2025.

Key Data:

 

  • Revenue: HKD 10.32 billion, up 18.5% year-on-year
  • Gross profit: HKD 946 million, down 1.8% year-on-year
  • Net profit attributable to shareholders: HKD 706 million, up 9.8% year-on-year
  • Earnings per share: HKD 1.02 (2024 H1: HKD 0.93)
  • Interim dividend: HKD 0.19 per share, up 26.7% year-on-year

 

Performance by Business Segment

 

  • Tobacco leaf import business: Revenue HKD 8.399 billion, up 23.5% year-on-year; however, gross profit margin declined, gross profit decreased by 7.7%.
  • Tobacco leaf export business: Revenue HKD 1.156 billion, up 25.9% year-on-year; gross profit increased by 124.1%, becoming the main driver of profit growth.
  • Cigarette export business: Sales volume decreased by 7.9%, but with structural optimization and expansion of self-operated channels, revenue remained basically flat (+0.8%), and gross profit increased by 16.8%.
  • New tobacco export business: Affected by geopolitical and regulatory factors, revenue was HKD 14.6 million, down 66.5% year-on-year.
China Tobacco Hong Kong 2025 Interim Results: Revenue HKD 10.3 billion, up 18.5% year-on-year; New Tobacco Export Business Revenue HKD 14.6 million, down 66.5% year-on-year
China Tobacco International (HK) Mid-term Financial Report screenshot for 2025 | Source: China Tobacco International (HK) Financial Report

 

Finance and Outlook

 

  • Financing cost: Down 28.2% to HKD 82.9 million, easing profit pressure.
  • Cash and deposits: HKD 3.98 billion, significantly increased compared with the end of 2024.
  • Outlook for the second half: The company emphasized that it will continue to strengthen the resilience of the tobacco leaf supply chain, expand duty-free cigarette channels, and promote innovation and market access for new tobacco products, in order to cope with international regulatory and geopolitical risks.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
Imperial Brands Launches 2ml+10ml blu MAX 6000 Vape System
mperial Brands has launched blu MAX 6000 in the UK, positioning the product as a higher-puff vape kit with longer-lasting use and replaceable pod+refill options. The device uses a 2ml+10ml click-on box format, with starter kits priced at £10.99 (approximately $14) and replacement pod+refill packs priced at £7.99 (approximately $10).
Market
May.19
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15
 NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
NYT: Reynolds American Donated $5 Million Before FDA Vape Policy Shift
According to The New York Times, Reynolds American donated $5 million to a Trump-backed super PAC shortly before the FDA introduced a new policy that could benefit major tobacco companies seeking to sell flavored vaping products.
News
May.21
State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner
State Registries Are Reshaping U.S. Vape Market Access 2Firsts Interview with U.S. Vapor Manufacturers Association President Allison Boughner
As the U.S. vapor market faces FDA authorizations, import seizures and growing state-level restrictions, AVM President Allison Boughner told 2Firsts that state product registries and white-list systems are having the most immediate impact. She said distributors are placing greater weight on documentation, product origin and supply-chain transparency.
Special Report
May.26
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
Reuters: Big Tobacco Emerges as Winner After FDA Regulatory Shift
According to Reuters, major tobacco companies may emerge as key beneficiaries after the U.S. FDA loosened regulations on vaping and nicotine pouch products, a shift that has sparked debate over public health risks.
Industry Insight
May.26
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Nicotine Beyond Tobacco? Cell Study Signals Emerging Shift in Production Systems
Researchers at the Chinese Academy of Sciences reconstructed nicotine biosynthesis in non-tobacco plants and yeast systems, highlighting how advances in synthetic biology could gradually reshape future nicotine production technologies and challenge regulatory frameworks built around tobacco-derived definitions.
Special Report
May.07